SUN C5174

Drug Profile

SUN C5174

Alternative Names: SUN C 5174

Latest Information Update: 18 Jun 2002

Price : $50

At a glance

  • Originator Suntory
  • Class
  • Mechanism of Action Alpha 1 adrenergic receptor agonists; Serotonin receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Arterial occlusive disorders

Most Recent Events

  • 18 Jun 2002 Discontinued - Phase-II for Arterial occlusive disorders in Japan (PO)
  • 17 Aug 2000 Phase-II clinical trials for Arterial occlusive disorders in Japan (PO)
  • 22 Oct 1999 New profile
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top